5498
A. A. El-Shehawy / Tetrahedron 63 (2007) 5490–5500
CH3CH2), 1.78–1.90 (1H, m, CH2CH3), 1.96–2.09 (1H, m,
CH2CH3), 2.32 (3H, s, Ar–CH3), 2.56 (3H, s, CH3–C6),
3.28 (1H, br s, NHC), 3.99–4.08 (1H, m, CHNH), 6.78–
6.98 (2H, m, HAr), 7.09–7.44 (2H, m, HAr), 12.29 (1H,
br s, SH); 13C NMR (100 MHz, CDCl3) d (ppm) 10.66
(CH3CH2), 16.69 (CH3–C6), 21.49 (Ar–CH3), 31.93
(CH2CH3), 57.36 (CHNH), 120.93 (CAr), 126.71 (CAr),
127.85 (CAr), 133.29 (CAr), 152.31 (C6), 165.92 (C5),
169.67 (C3); MS (EI) (m/z, relative intensity) 290 (M+, 9),
262 (33), 246 (6.5), 218 (8), 158 (11), 146 (56), 134 (14),
131 (38), 119 (13), 109 (29), 105 (14), 91 (6).
(400 MHz, CDCl3) d (ppm) 0.87 (3H, t, J¼7.5 Hz,
CH3CH2), 1.75–1.92 (1H, m, CH2CH3), 1.98–2.11 (1H, m,
CH2CH3), 2.42 (3H, s, CH3–C6), 3.34 (1H, br s, NHC),
3.82 (3H, s, OCH3), 4.09–4.17 (1H, m, CHNH), 6.93
(2H, d, J¼8.7, HAr), 7.26 (2H, d, J¼8.7, HAr), 11.87
(1H, br s, SH); 13C NMR (100 MHz, CDCl3) d (ppm)
11.7 (CH3CH2), 17.87 (CH3–C6), 31.3 (CH2CH3), 55.59
(OCH3), 56.44 (CHNH), 115.87 (CAr), 126.67 (CAr),
134.72 (CAr), 146.43 (CAr), 152.52 (C6), 164.55 (C5),
171.09 (C3); MS (EI) (m/z, relative intensity) 306 (M+,
18), 279 (22), 262 (6), 234 (4), 157 (24), 150 (21), 146
(64), 130 (16), 119 (9), 105 (7).
4.4.3. 4-[1-(40-Methylphenyl)propyl]amino-3-mercapto-
6-methyl-4H-1,2,4-triazin-5-one 4c. White solid, mp
182–183 ꢁC; [a]D25 ꢀ78.1 (c 1.28, CH2Cl2); HPLC condi-
tions: 15% i-PrOH in hexane, retention times, 21.55 min
(minor, R-isomer) and 27.82 min (major, S-isomer); Anal.
Calcd for C14H18N4OS: C, 57.91; H, 6.25; N, 19.29; S,
11.04. Found: C, 57.87; H, 6.30; N, 19.23; S, 11.12; IR
4.4.6. 4-[1-(20,40,60-Tri-methylphenyl)propyl]amino-3-
mercapto-6-methyl-4H-1,2,4-triazin-5-one 4f. White
solid, mp 198–199 ꢁC; [a]D25 ꢀ46.6 (c 0.98, CH2Cl2);
HPLC conditions: 15% i-PrOH in hexane, retention times,
12.82 min (minor, R-isomer) and 19.42 min (major, S-iso-
mer); Anal. Calcd for C16H22N4OS: C, 60.35; H, 6.96; N,
17.59; S, 10.07. Found: C, 60.31; H, 6.99; N, 17.58; S,
10.11; IR (cmꢀ1) 3283 (NH), 1704 (C]O), 1205 (C]S); 1H
NMR (400 MHz, CDCl3) d (ppm) 0.91 (3H, t, J¼7.7 Hz,
CH3CH2), 1.72 (3H, s, Ar–CH3), 1.84–1.96 (1H, m,
CH2CH3), 2.01–2.11 (1H, m, CH2CH3), 2.21 (6H, s, Ar–
CH3), 2.31 (3H, s, Ar–CH3), 2.40 (3H, s, CH3–C6), 3.39 (1H,
br s, NHC), 4.16–4.31 (1H, m, CHNH), 6.72 (1H, s, HAr),
6.89 (1H, s, HAr), 7.31 (1H, s, HAr), 11.57 (1H, br s, SH);
13C NMR (100 MHz, CDCl3) d (ppm) 11.18 (CH3CH2),
17.12 (CH3–C6), 19.98 (Ar–CH3), 20.55 (Ar–CH3), 21.95
(Ar–CH3), 31.8 (CH2CH3), 53.44 (CHNH), 128.31 (CAr),
131.67 (CAr), 136.19 (CAr), 139.52 (CAr), 152.18 (C6),
165.49 (C5), 169.78 (C3); MS (EI) (m/z, relative intensity)
318 (M+, 13), 290 (21), 274 (4), 246 (7), 175 (32), 162
(29), 158 (23), 146 (61), 131 (33), 118 (17), 105 (8), 91 (12).
1
(cmꢀ1) 3280 (NH), 1703 (C]O), 1208 (C]S); H NMR
(400 MHz, CDCl3) d (ppm) 0.86 (3H, t, J¼7.6 Hz,
CH3CH2), 1.74–1.87 (1H, m, CH2CH3), 1.97–2.13 (1H, m,
CH2CH3), 2.35 (3H, s, Ar–CH3), 2.44 (3H, s, CH3–C6),
3.42 (1H, br s, NHC), 4.06–4.16 (1H, m, CHNH), 7.07
(2H, d, J¼8.3, HAr), 7.18 (2H, d, J¼8.3, HAr), 11.57 (1H,
br s, SH); 13C NMR (100 MHz, CDCl3) d (ppm) 10.95
(CH3CH2), 16.92 (CH3–C6), 21.64 (Ar–CH3), 32.2
(CH2CH3), 54.65 (CHNH), 125.88 (CAr), 128.84 (CAr),
136.38 (CAr), 140.69 (CAr), 150.43 (C6), 166.76 (C5),
170.18 (C3); MS (EI) (m/z, relative intensity) 290 (M+,
11), 263 (27), 246 (9.5), 218 (4), 158 (9), 146 (52), 134
(18), 130 (25), 119 (21), 105 (9), 91 (19).
4.4.4. 4-[1-(20-Methoxyphenyl)propyl]amino-3-mer-
capto-6-methyl-4H-1,2,4-triazin-5-one 4d. White solid, mp
129–131 ꢁC; [a]D25 ꢀ94.5 (c 0.77, CHCl3); HPLC conditions:
15% i-PrOH in hexane, retention times, 10.41 min (minor, R-
isomer) and 18.16 min (major, S-isomer); Anal. Calcd for
C14H18N4O2S: C, 54.88; H, 5.92; N, 18.29; S, 10.47. Found:
C, 54.79; H, 5.97; N, 18.36; S, 10.38; IR (cmꢀ1) 3285 (NH),
4.5. General procedure for the reductive cleavage
of the 1,2,4-triazinyl heterocyclic ring
To a stirred solution of 4-(1-arylpropyl)amino-3-mercapto-
6-methyl-4H-1,2,4-triazin-5-one 4 (3 mmol) in ethanol
(15 mL), concd HCl (5 mL) and Zn (0.2 g) were added
and the reaction mixture was heated under reflux at 55–
60 ꢁC for 24 h (TLC-control). The solvent was evaporated
and 1.5 M aqueous HCl (15 mL) was added. The reaction
mixture was then extracted with diethyl ether (3ꢂ10 mL).
The aqueous layer was basified with 15% aqueous NaOH
and extracted with ethyl acetate (3ꢂ15 mL). The combined
organic layers were dried over MgSO4 and the solvent was
removed in vacuo. Purification by flash chromatography (de-
activated silica gel, pentane/ether: 95:5 to 80:20) afforded
the pure 1-arylpropylamine. All the physical and spectro-
scopic data for compounds 11a–f were in complete agree-
ment with the reported data.12 The absolute configurations
of the major isomer of addition products 4a–f were assigned
based on the absolute configuration of 11a–f and comparison
of the HPLC retention times with the literature values.11,12
The ee values of the (S)-1-arylpropylamines 11a–f were de-
termined by HPLC analysis after their derivation to the cor-
responding acetamide derivatives by reported method12d by
treatment with acetic anhydride and triethylamine and com-
parison with the literature value.12 The ee values determined
by HPLC were found to be in very good agreement with the
enantioselectivities of the starting secondary amines 4a–f.
1
1795 (C]O), 1209 (C]S); H NMR (400 MHz, CDCl3)
d (ppm) 0.76 (3H, t, J¼7.4 Hz, CH3CH2), 1.74–1.89 (1H,
m, CH2CH3), 1.96–2.05 (1H, m, CH2CH3), 2.37 (3H, s,
CH3–C6), 3.28 (1H, br s, NHC), 3.83 (3H, s, OCH3), 4.38–
4.52 (1H, m, CHNH), 6.98 (1H, d, J¼8.0 Hz, HAr), 7.09
(1H, t, J¼7.6 Hz, HAr), 7.35 (1H, t, J¼7.6 Hz, HAr), 7.59
(1H, d, J¼7.6, HAr), 8.08 (1H, dd, J¼1.94, 1.77, HAr), 12.44
(1H, br s, SH); 13C NMR (100 MHz, CDCl3) d (ppm) 10.93
(CH3CH2), 17.49 (CH3–C6), 32.29 (CH2CH3), 53.49
(OCH3), 57.62 (CHNH), 121.73 (CAr), 127.52 (CAr), 128.21
(CAr), 131.89 (CAr), 151.09 (C6), 165.87 (C5), 170.19 (C3);
MS (EI) (m/z, relative intensity) 306 (M+, 14), 278 (19), 262
(11), 234 (5), 157 (13), 146 (76), 150 (26), 131 (28), 118
(17), 105 (13), 91 (37), 91 (11).
4.4.5. 4-[1-(40-Methoxyphenyl)propyl]amino-3-mer-
capto-6-methyl-4H-1,2,4-triazin-5-one 4e. White solid, mp
144–145 ꢁC; [a]D25 ꢀ34.6 (c 2.39, CH2Cl2); HPLC condi-
tions: 15% i-PrOH in hexane, retention times, 9.32 min (mi-
nor, R-isomer) and 15.52 min (major, S-isomer); Anal. Calcd
for C14H18N4O2S: C, 54.88; H, 5.92; N, 18.29; S, 10.47.
Found: C, 55.01; H, 5.89; N, 18.33; S, 10.45; IR (cmꢀ1
3285 (NH), 1695 (C]O), 1210 (C]S); 1H NMR
)